Literature DB >> 943694

e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants.

K Okada, I Kamiyama, M Inomata, M Imai, Y Miyakawa.   

Abstract

Testing of serum samples of 23 pregnant women who were asymptomatic carriers of hepatitis B surface antigen for e antigen and antibody to e with an immunodiffusion technic identified 10 mothers with e antigen and seven with e antibody. Their babies were tested for hepatitis B surface antigen in serum at intervals for more than 12 months. In all 10 babies born to e-antigen-positive mothers hepatitis B surface antigen developed and persisted through the observation period, and all 10 elder siblings of these newborn babies were found to be asymptomatic carriers. In remarkable contrast, all seven babies born to mothers positive for antibody to e escaped antigenemia, and none of their three elder siblings carried surface antigen. On the basis of these results, e antigen may be used as an indicator of transmission, and antibody to e as that of absence of transmission of hepatitis B virus from carrier mothers to children.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943694     DOI: 10.1056/NEJM197604012941402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  126 in total

1.  Age-related differences in amplification of covalently closed circular DNA at early times after duck hepatitis B virus infection of ducks.

Authors:  Yong-Yuan Zhang; Daniel P Theele; Jesse Summers
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 2.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: single center study in Egypt.

Authors:  Hanaa M El-Karaksy; Lamiaa M Mohsen; Doa'a A Saleh; Mona S Hamdy; Noha A Yassin; Mohamed Farouk; Mohamed E Salit; Mortada H El-Shabrawi
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

5.  Lack of supportive evidence for an autosomal recessive inheritance in chronic hepatitis B infections.

Authors:  M J Tong; J M Weiner
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

6.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03

Review 7.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

8.  Naturally occurring infection of Pekin duck embryos by duck hepatitis B virus.

Authors:  A P O'Connell; M K Urban; W T London
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)].

Authors:  B Stamm; W Gerlich; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1979-05-15       Impact factor: 3.402

10.  Perinatal hepatitis B virus detection by hepatitis B virus-DNA analysis.

Authors:  S De Virgiliis; F Frau; G Sanna; M P Turco; A L Figus; G Cornacchia; A Cao
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.